Thomas Andre, Ph.D

Iowa State University, Ames, IA, United States 
"Thomas Andre"
Mean distance: 18.74 (cluster 9)
Cross-listing: PsychTree


Sign in to add trainee
Jeffrey M. Kenton grad student 2002 Iowa State (PsychTree)
Eun-Mi Yang grad student 2003 Iowa State (PsychTree)
Han-Chin Liu grad student 2005 Iowa State (PsychTree)
Yasemin Demiraslan Cevik grad student 2011 Iowa State (PsychTree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

André T, de Gramont A, Vernerey D, et al. (2015) Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Maillet M, Glehen O, Lambert J, et al. (2015) Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study. Annals of Surgical Oncology
Tournigand C, Chibaudel B, Samson B, et al. (2015) Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. The Lancet. Oncology. 16: 1493-505
Bachet JB, Chibaudel B, Bonnetain F, et al. (2015) A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial. Bmc Cancer. 15: 653
Bachet JB, Gay F, Maréchal R, et al. (2015) Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma. Pancreas. 44: 1141-7
Peeters M, Oliner K, Price TJ, et al. (2015) Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Serdjebi C, Gagnière J, Desramé J, et al. (2015) FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients. Plos One. 10: e0135907
Jary M, Borg C, Bouché O, et al. (2015) [Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense?]. Bulletin Du Cancer. 102: 758-71
Chibaudel B, Bonnetain F, Tournigand C, et al. (2015) STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer. Bmc Cancer. 15: 496
Cohen R, Cervera P, Svrcek M, et al. (2015) [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?]. Bulletin Du Cancer. 102: S72-81
See more...